The University of Arkansas for Medical Sciences and Arkansas Children’s are bracing for funding cuts from the Trump administration’s new policy setting a 15% cap on payments for indirect costs related to research from the National Institutes of Health (NIH). The impact of this policy change would be significant for UAMS and other research institutions in Arkansas and nationally.
UAMS Chancellor Dr. Cam Patterson and Arkansas Children’s President Marcy Doderer have warned their faculty and staff about the immediate and devastating effects on research programs due to the new cap. Tens of millions of dollars in NIH funding that support medical research projects on maternal health disparities, immune cells, high blood pressure, and cancer-related viruses at UAMS are at risk.
The 15% cap on indirect costs would result in a loss of more than $10 million annually for UAMS, making it difficult for the university to sustain its research initiatives. Arkansas Children’s, the second largest recipient of NIH funding in the state, could also face a major setback in pediatric research.
In response to the policy change, UAMS and Arkansas Children’s are collaborating with congressional leaders, including U.S. Sen. John Boozman, to address the impact on their research programs and advocate against the funding cuts. Legal actions by attorneys general from 22 states, including a lawsuit to block the NIH policy change, have been initiated to challenge the Trump administration’s decision. The research community is rallying against these cuts that threaten the future of life-saving breakthroughs in scientific research.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
